Education
About Us
Working with TipRanks
Follow Us
BioStem Technologies Inc (BSEM)
OTHER OTC:BSEM
RESEARCH TOOLSreports
Earnings Data
Report Date
Aug 26, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.32Last Year’s EPS
0.3Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 12, 2025
|% Change Since: -8.55%
|Next Earnings Date:Aug 26, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth and profitability achievements for BioStem Technologies, underscoring the company's operational strength and financial resilience. Despite challenges such as increased operating expenses and market uncertainty due to LCD delays, the company remains on a positive trajectory with ongoing clinical trials and strategic initiatives. The sentiment is bolstered by strong cash reserves and gross profit margins, although the pending SEC review for NASDAQ uplisting presents a potential hurdle.Company Guidance
In the first quarter of 2025, BioStem Technologies reported a record-breaking revenue of $72.5 million, marking a significant 73% increase year-over-year and achieving profitability for the fifth consecutive quarter. The company's GAAP net income was $4.5 million, equivalent to $0.27 per share, and they reported an adjusted EBITDA of $7.8 million. The quarter ended with BioStem holding $26.7 million in cash, up from $22.8 million in the previous quarter. Despite challenges posed by the LCD's uncertainty, which affected sequential growth, BioStem's strategy to transition customers to VENDAJE AC is expected to reduce SG&A costs, as the product does not carry licensing fees. The company's partnership with Venture Medical is expanding, with over 150 sales reps and plans to add 1,099 more, alongside a new 40-person direct sales team. BioStem's focus on clinical trials continues, with three active programs, including a new trial for venous leg ulcers. Additionally, they are advancing in their efforts to up-list to NASDAQ, a move expected to enhance their shareholder base and market visibility.Record Revenue Growth
BioStem Technologies delivered its strongest first quarter revenue in company history, with revenue increasing 73% year-over-year to $72.5 million.
Profitability Achievement
Reported GAAP net income of $4.5 million or $0.27 per share, marking the fifth consecutive quarter of profitability.
Strong Financial Position
BioStem ended the quarter with $26.7 million in cash, an increase from $22.8 million in Q4 2024.
Gross Profit Margin Improvement
Gross profit was $71.7 million, or 99% of net revenue, compared to 95% in Q1 2024, reflecting product mix benefits and scale efficiencies.
Clinical Trial Progress
Initiated a new clinical trial for BioREtain Amnion Chorion and received IRB approval. Progress is being made in existing trials with data readouts expected by mid to late 2025.
BSEM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BSEM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2025 | $15.20 | $12.63 | -16.91% |
Apr 14, 2025 | $12.89 | $10.70 | -16.99% |
Nov 12, 2024 | $24.72 | $24.98 | +1.05% |
Aug 12, 2024 | $12.50 | $13.55 | +8.40% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does BioStem Technologies Inc (BSEM) report earnings?
BioStem Technologies Inc (BSEM) is schdueled to report earning on Aug 26, 2025, TBA Not Confirmed.
What is BioStem Technologies Inc (BSEM) earnings time?
BioStem Technologies Inc (BSEM) earnings time is at Aug 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BSEM EPS forecast?
BSEM EPS forecast for the fiscal quarter 2025 (Q2) is 0.32.